Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318


Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).

de Groot S, Pijl H, Charehbili A, van de Ven S, Smit VTHBM, Meershoek-Klein Kranenbarg E, Heijns JB, van Warmerdam LJC, Kessels LW, Dercksen MW, Pepels MJAE, van Laarhoven HWM, Vriens BEPJ, Putter H, Fiocco M, Liefers GJ, van der Hoeven JJM, Nortier JWR, Kroep JR; Dutch Breast Cancer Research Group.

Breast Cancer Res. 2019 Aug 28;21(1):97. doi: 10.1186/s13058-019-1180-6.


Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.

Jelaković B, Dika Ž, Arlt VM, Stiborova M, Pavlović NM, Nikolić J, Colet JM, Vanherweghem JL, Nortier JL.

Semin Nephrol. 2019 May;39(3):284-296. doi: 10.1016/j.semnephrol.2019.02.007. Review.


Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.

de Groot AF, Blok EJ, Charehbili A, Engels CC, Smit VTHBM, Dekker-Ensink NG, Putter H, Meershoek-Klein Kranenbarg E, van de Velde CJH, Liefers GJ, Nortier JWR, Kuppen PJK, van der Burg SH, Kroep JR.

Breast Cancer Res Treat. 2019 Jun;175(3):605-615. doi: 10.1007/s10549-019-05195-y. Epub 2019 Mar 13.


Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.

Derks MGM, van de Velde CJH, Giardiello D, Seynaeve C, Putter H, Nortier JWR, Dirix LY, Bastiaannet E, Portielje JEA, Liefers GJ.

Oncologist. 2019 Jul;24(7):e467-e474. doi: 10.1634/theoncologist.2018-0010. Epub 2019 Jan 3.


Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.

Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Nieboer P, van der Hoeven JJM, Smorenburg CH.

Support Care Cancer. 2019 May;27(5):1919-1925. doi: 10.1007/s00520-018-4432-6. Epub 2018 Sep 11.


Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.

Derks MGM, Bastiaannet E, van de Water W, de Glas NA, Seynaeve C, Putter H, Nortier JWR, Rea D, Hasenburg A, Markopoulos C, Dirix LY, Portielje JEA, van de Velde CJH, Liefers GJ.

Eur J Cancer. 2018 Aug;99:1-8. doi: 10.1016/j.ejca.2018.04.009. Epub 2018 Jun 6.


Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH; IDEAL and TEAM Study Groups.

Eur J Cancer. 2018 May;95:59-67. doi: 10.1016/j.ejca.2018.03.014. Epub 2018 Apr 7.


CD4+ and CD8+ T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy.

Baudoux T, Husson C, De Prez E, Jadot I, Antoine MH, Nortier JL, Hougardy JM.

Sci Rep. 2018 Mar 28;8(1):5334. doi: 10.1038/s41598-018-23565-2.


Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.

Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Smorenburg CH, van der Hoeven JJM.

Eur J Oncol Nurs. 2018 Apr;33:49-55. doi: 10.1016/j.ejon.2018.01.001. Epub 2018 Feb 3.


Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

Wapnir IL, Price KN, Anderson SJ, Robidoux A, Martín M, Nortier JWR, Paterson AHG, Rimawi MF, Láng I, Baena-Cañada JM, Thürlimann B, Mamounas EP, Geyer CE Jr, Gelber S, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S; International Breast Cancer Study Group; NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists' Group; Breast International Group.

J Clin Oncol. 2018 Apr 10;36(11):1073-1079. doi: 10.1200/JCO.2017.76.5719. Epub 2018 Feb 14.


Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer.

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH; IDEAL Study Group.

Breast Cancer Res Treat. 2018 Apr;168(2):413-420. doi: 10.1007/s10549-017-4601-1. Epub 2017 Dec 12.


False-positive galactomannan assay in broncho-alveolar lavage after enteral nutrition solution inhalation: a case report.

Lheureux O, Montesinos I, Taton O, Antoine M, Preiser JC, Nortier J, Creteur J, Jacobs F, Grimaldi D.

JMM Case Rep. 2017 Sep 18;4(9):e005116. doi: 10.1099/jmmcr.0.005116. eCollection 2017 Sep.


Severe myoglobinuric acute kidney injury in a kidney recipient: rapid recovery after hemodialysis with the super high-flux membrane Theralite®

Goubella A, Gankam-Kengne F, Baudoux T, Fagnoul D, Husson C, Delforge ML, Broeders N, Nortier JL.

Clin Nephrol. 2017 Dec;88(12):359-363. doi: 10.5414/CN109020.


[Diagnosis and treatment of nephrolithiasis and prevention of recurrences].

Simon I, Legrand F, Des Grottes JM, Cotton F, Nortier J, Roumeguère T.

Rev Med Brux. 2017;38(4):279-283. French.


[Clinical care pathway for chronic kidney disease : development and perspectives].

Nortier J, Plennevaux V, Nolf A, Hougardy JM, Petit AD.

Rev Med Brux. 2017;38(4):271-278. French.


Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers.

Bunel V, Tournay Y, Baudoux T, De Prez E, Marchand M, Mekinda Z, Maréchal R, Roumeguère T, Antoine MH, Nortier JL.

Clin Kidney J. 2017 Oct;10(5):639-647. doi: 10.1093/ckj/sfx007. Epub 2017 Mar 27.


Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, Maartense E, van Leeuwen-Stok AE, Liefers GJ, Nortier JWR, Rutgers EJT, van de Velde CJH; IDEAL Study Group.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx134.


Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy.

Jadot I, Colombaro V, Martin B, Habsch I, Botton O, Nortier J, Declèves AE, Caron N.

PLoS One. 2017 Aug 23;12(8):e0183604. doi: 10.1371/journal.pone.0183604. eCollection 2017.


Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.

Fischer MJ, Inoue K, Matsuda A, Kroep JR, Nagai S, Tozuka K, Momiyama M, Weijl NI, Langemeijer-Bosman D, Ramai SRS, Nortier JWR, Putter H, Yamaoka K, Kubota K, Kobayashi K, Kaptein AA.

Breast Cancer Res Treat. 2017 Nov;166(2):459-471. doi: 10.1007/s10549-017-4417-z. Epub 2017 Jul 31.


Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

Derks MGM, Blok EJ, Seynaeve C, Nortier JWR, Kranenbarg EM, Liefers GJ, Putter H, Kroep JR, Rea D, Hasenburg A, Markopoulos C, Paridaens R, Smeets JBE, Dirix LY, van de Velde CJH.

Lancet Oncol. 2017 Sep;18(9):1211-1220. doi: 10.1016/S1470-2045(17)30419-9. Epub 2017 Jul 18.


Protective Effects of Pistacia lentiscus L. fruit extract against calcium oxalate monohydrate induced proximal tubular injury.

Cheraft-Bahloul N, Husson C, Ourtioualous M, Sinaeve S, Atmani D, Stévigny C, Nortier JL, Antoine MH.

J Ethnopharmacol. 2017 Sep 14;209:248-254. doi: 10.1016/j.jep.2017.07.018. Epub 2017 Jul 14.


Interest of metabonomic approach in environmental nephrotoxicants: Application to aristolochic acid exposure.

Duquesne M, Declèves AE, De Prez E, Nortier J, Colet JM.

Food Chem Toxicol. 2017 Oct;108(Pt A):19-29. doi: 10.1016/j.fct.2017.07.015. Epub 2017 Jul 8. No abstract available.


An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Jadot I, Declèves AE, Nortier J, Caron N.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E297. doi: 10.3390/ijms18020297. Review.


Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04).

Fontein DB, Charehbili A, Nortier JW, Putter H, Kranenbarg EM, Kroep JR, Linn SC, van de Velde CJ.

Eur J Surg Oncol. 2017 Apr;43(4):619-624. doi: 10.1016/j.ejso.2016.07.146. Epub 2016 Dec 10.


Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.

Komen MMC, Smorenburg CH, Nortier JWR, van der Ploeg T, van den Hurk CJG, van der Hoeven JJM.

Breast. 2016 Dec;30:105-110. doi: 10.1016/j.breast.2016.09.007. Epub 2016 Sep 28.


Donor Cancer Transmission in Kidney Transplantation.

Baudoux TER, Gastaldello K, Rorive S, Hamade A, Broeders N, Nortier JL.

Kidney Int Rep. 2016 Sep 29;2(2):134-137. doi: 10.1016/j.ekir.2016.09.057. eCollection 2017 Mar. No abstract available.


Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

Wapnir IL, Gelber S, Anderson SJ, Mamounas EP, Robidoux A, Martín M, Nortier JW, Geyer CE Jr, Paterson AH, Láng I, Price KN, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S; CALOR trial investigators.

Ann Surg Oncol. 2017 Feb;24(2):398-406. doi: 10.1245/s10434-016-5571-y. Epub 2016 Sep 23.


Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?

Pozdzik A, Beukinga I, Gu-Trantien C, Willard-Gallo K, Nortier J, Pradier O.

Mediators Inflamm. 2016;2016:7651024. doi: 10.1155/2016/7651024. Epub 2016 Jul 14.


Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats.

Pozdzik AA, Giordano L, Li G, Antoine MH, Quellard N, Godet J, De Prez E, Husson C, Declèves AE, Arlt VM, Goujon JM, Brochériou-Spelle I, Ledbetter SR, Caron N, Nortier JL.

PLoS One. 2016 Jul 5;11(7):e0157288. doi: 10.1371/journal.pone.0157288. eCollection 2016.


Implémentation des trajets de soins de l'insuffisance rénale chronique: bénéfices pour le patient et perspectives en termes de santé publique.

Ben Omar Bridi S, PIennevaux V, Racapé J, Nortier J.

Rev Med Brux. 2016 Jan-Feb;37(1):5-12. French.


Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.

Komen MM, Breed WP, Smorenburg CH, van der Ploeg T, Goey SH, van der Hoeven JJ, Nortier JW, van den Hurk CJ.

Support Care Cancer. 2016 Jun;24(6):2735-41. doi: 10.1007/s00520-016-3084-7. Epub 2016 Jan 25.


Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials.

Kroep JR, Charehbili A, Coleman RE, Aft RL, Hasegawa Y, Winter MC, Weilbaecher K, Akazawa K, Hinsley S, Putter H, Liefers GJ, Nortier JWR, Kohno N.

Eur J Cancer. 2016 Feb;54:57-63. doi: 10.1016/j.ejca.2015.10.011. Epub 2015 Dec 23.


Encapsulating Peritoneal Sclerosis In a Kidney Graft Recipient Unmasked by Everolimus Switch.

Pozdzik AA, Fernandez V, Demetter P, Tooulou M, Matos C, Gammar N, Broeders N, Dratwa M, Nortier J.

Perit Dial Int. 2015 Dec;35(7):769-71. doi: 10.3747/pdi.2014.00157. No abstract available.


New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity.

Bunel V, Antoine MH, Stévigny C, Nortier J, Duez P.

Food Chem Toxicol. 2016 Jan;87:77-87. doi: 10.1016/j.fct.2015.11.020. Epub 2015 Nov 27.


Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01).

Charehbili A, Hamdy NA, Smit VT, Kessels L, van Bochove A, van Laarhoven HW, Putter H, Meershoek-Klein Kranenbarg E, van Leeuwen-Stok AE, van der Hoeven JJ, van de Velde CJ, Nortier JW, Kroep JR; Dutch Breast Cancer Research Group (BOOG).

Breast. 2016 Feb;25:69-74. doi: 10.1016/j.breast.2015.10.005. Epub 2015 Nov 21.


[Aristolochic acid nephropathy ("Chinese herb nephropathy")].

Nortier J, Pozdzik A, Roumeguere T, Vanherweghem JL.

Nephrol Ther. 2015 Dec;11(7):574-88. doi: 10.1016/j.nephro.2015.10.001. Epub 2015 Oct 26. French.


Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets.

Declèves AÉ, Jadot I, Colombaro V, Martin B, Voisin V, Nortier J, Caron N.

Exp Physiol. 2016 Jan;101(1):193-206. doi: 10.1113/EP085333. Epub 2015 Dec 6.


The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study.

de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, Houtsma D, Putter H, van der Hoeven JJ, Nortier JW, Pijl H, Kroep JR.

BMC Cancer. 2015 Oct 5;15:652. doi: 10.1186/s12885-015-1663-5.


[Recurrent episodes of brushite nephrolithiasis revealing primary hyperparathyroidism].

Simon I, Roumeguère T, Devuyst F, Cotton F, Tang BN, Cappello M, Corbetta S, Idrissi M, Pozdzik A, Nortier J.

Rev Med Brux. 2015 May-Jun;36(3):172-6. French.


[Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].

Pozdzik AA, Debiec H, I Brochériou, Husson C, Rorive S, Broeders N, Le Moine A, Ronco P, Nortier J.

Rev Med Brux. 2015 May-Jun;36(3):166-71. Review. French.


CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects.

Dezentjé VO, Opdam FL, Gelderblom H, Hartigh den J, Van der Straaten T, Vree R, Maartense E, Smorenburg CH, Putter H, Dieudonné AS, Neven P, Van de Velde CJ, Nortier JW, Guchelaar HJ.

Breast Cancer Res Treat. 2015 Oct;153(3):583-90. doi: 10.1007/s10549-015-3562-5. Epub 2015 Sep 14.


Morphological Retrospective Study of Peritoneal Biopsies from Patients with Encapsulating Peritoneal Sclerosis: Underestimated Role of Adipocytes as New Fibroblasts Lineage?

Tooulou M, Demetter P, Hamade A, Keyzer C, Nortier JL, Pozdzik AA.

Int J Nephrol. 2015;2015:987415. doi: 10.1155/2015/987415. Epub 2015 Aug 19.


Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.

Charehbili A, de Groot S, van der Straaten T, Swen JJ, Pijl H, Gelderblom H, van de Velde CJ, Nortier JW, Guchelaar HJ, Kroep JR.

Pharmacogenomics. 2015;16(11):1267-76. doi: 10.2217/PGS.15.74. Epub 2015 Aug 20.


[Dialysis treatment for diabetic patients].

Nortier J.

Soins. 2015 Mar;(794 Suppl):S18-20. French.


Intensive care admission of cancer patients: a comparative analysis.

Bos MM, Verburg IW, Dumaij I, Stouthard J, Nortier JW, Richel D, van der Zwan EP, de Keizer NF, de Jonge E.

Cancer Med. 2015 Jul;4(7):966-76. doi: 10.1002/cam4.430. Epub 2015 Apr 18.


Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial.

Fontein DB, Klinten Grand M, Nortier JW, Seynaeve C, Meershoek-Klein Kranenbarg E, Dirix LY, van de Velde CJ, Putter H.

Ann Oncol. 2015 Jun;26(6):1254-62. doi: 10.1093/annonc/mdv146. Epub 2015 Apr 10.


In vitro effects of Panax ginseng in aristolochic acid-mediated renal tubulotoxicity: apoptosis versus regeneration.

Bunel V, Antoine MH, Nortier J, Duez P, Stévigny C.

Planta Med. 2015 Mar;81(5):363-72. doi: 10.1055/s-0035-1545839. Epub 2015 Mar 23.


Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: toxicological implications.

Yamani A, Bunel V, Antoine MH, Husson C, Stévigny C, Duez P, Elachouri M, Nortier J.

J Ethnopharmacol. 2015 May 26;166:250-60. doi: 10.1016/j.jep.2015.03.036. Epub 2015 Mar 19.


Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors.

Fischer MJ, Krol-Warmerdam EM, Ranke GM, Vermeulen HM, Van der Heijden J, Nortier JW, Kaptein AA.

J Psychosoc Oncol. 2015;33(3):278-96. doi: 10.1080/07347332.2015.1020465.


Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial.

Dekker TJ, Charehbili A, Smit VT, ten Dijke P, Kranenbarg EM, van de Velde CJ, Nortier JW, Tollenaar RA, Mesker WE, Kroep JR.

Mol Oncol. 2015 Jun;9(6):1120-8. doi: 10.1016/j.molonc.2015.02.001. Epub 2015 Feb 14.

Supplemental Content

Loading ...
Support Center